Deadly Ebola virus on the brink of being tamed
Preliminary analysis of 499 Ebola infected participants has sprung a surprise — the chances of survival may be as high as 90% if patients are treated with one of the…
A Science and Technology Blog
Preliminary analysis of 499 Ebola infected participants has sprung a surprise — the chances of survival may be as high as 90% if patients are treated with one of the…
Merck’s Ebola vaccine, which underwent phase-3 trial during the 2014-2015 Ebola epidemic in west Africa, has shown 97.5% efficacy in preventing Ebola disease when used during the current epidemic in…
On July 17, the WHO finally declared Ebola virus disease outbreak in Congo a Public Health Emergency of International Concern. Since the beginning of the outbreak in August 2018, Ebola…
Days after the WHO declared the end of the May 8 Ebola outbreak in the Democratic Republic of the Congo, a fresh outbreak was reported on August 1 in North Kivu. If…
The alacrity and eagerness shown by the research community to find a safe and efficacious vaccine against the deadly Ebola virus has borne fruit. The interim results of a Phase…